Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines.

MLA

Yamout, B., et al. “Consensus Recommendations for Diagnosis and Treatment of Multiple Sclerosis: 2023 Revision of the MENACTRIMS Guidelines.” Multiple Sclerosis & Related Disorders, vol. 83, Mar. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.msard.2024.105435.

APA

Yamout, B., Al-Jumah, M., Sahraian, M. A., Almalik, Y., Khaburi, J. A., Shalaby, N., Aljarallah, S., Bohlega, S., Dahdaleh, M., Almahdawi, A., Khoury, S. J., Koussa, S., Slassi, E., Daoudi, S., Aref, H., Mrabet, S., Zeineddine, M., Zakaria, M., Inshasi, J., & Gouider, R. (2024). Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines. Multiple Sclerosis & Related Disorders, 83, N.PAG. https://doi.org/10.1016/j.msard.2024.105435

Chicago

Yamout, B., M. Al-Jumah, M.A. Sahraian, Y Almalik, J. Al Khaburi, N. Shalaby, S Aljarallah, et al. 2024. “Consensus Recommendations for Diagnosis and Treatment of Multiple Sclerosis: 2023 Revision of the MENACTRIMS Guidelines.” Multiple Sclerosis & Related Disorders 83 (March): N.PAG. doi:10.1016/j.msard.2024.105435.